Celldex Therapeutics Inc (CLDX)
R&D Expense Growth
-7.47%
Quarterly · Period ending:
CLDX R&D Expense Growth
Latest reported-7.47%period ending
Latest reported-7.47%period ending
CLDX Quarterly R&D Growth (QoQ) (0.00% → -7.47%)
Latest values, visible window
High-resolution chart · PNG
CLDX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -7.4684% | |
| -3.129% | |
| 19.7486% | |
| 16.1174% | |
| 3.0068% | |
| 14.0807% | |
| 1.8934% | |
| 16.3872% | |
| 25.9147% | |
| 1.5119% | |
| -11.8981% | |
| 31.5519% | |
| -2.0375% | |
| 17.0269% | |
| 6.1515% | |
| 4.0567% | |
| 21.5467% | |
| 16.2011% | |
| -13.9474% | |
| 38.0463% | |
| -2.8616% | |
| -55.2507% | |
| 165.4557% | |
| -18.9095% | |
| 12.9115% | |
| 13.1154% | |
| -6.8642% | |
| 10.118% | |
| -9.5956% | |
| -0.4997% | |
| -5.9658% | |
| -44.433% | |
| -1.952% | |
| -6.7721% | |
| 7.0682% | |
| -12.3365% | |
| -3.0784% | |
| 5.0289% | |
| -1.8034% | |
| -2.7303% | |
| -6.3249% | |
| 14.841% | |
| -3.0662% | |
| -6.9234% | |
| 5.4328% | |
| -7.034% | |
| 3.2118% | |
| 8.6515% | |
| -10.9716% | |
| 52.0445% | |
| -12.7982% | |
| 35.3015% | |
| 7.0972% | |
| 2.4876% | |
| 16.8154% | |
| 5.8935% | |
| 3.2036% | |
| 9.6193% | |
| 14.3123% | |
| 19.8772% | |
| 4.6111% | |
| 1.6464% | |
| -6.5558% | |
| -0.565% | |
| 12.7058% | |
| 163.8525% | |
| -66.303% | |
| -7.1905% | |
| -10.1767% | |
| 14.231% | |
| 14.7565% | |
| -12.9486% | |
| 69.6467% | |
| 9.1146% | |
| -7.7509% | |
| -10.2696% | |
| 61,334.9369% | |
| -99.8328% | |
| 9.5361% | |
| -1.0659% | |
| 2.6489% | |
| 44.4585% | |
| -16.1774% | |
| 4.6733% | |
| -14.8768% | |
| -5.0949% | |
| 51.365% | |
| -16.6875% | |
| -2.4731% | |
| 60.9658% | |
| -14.5333% | |
| -6.1083% | |
| -0.7094% | |
| -4.1576% | |
| -17.9335% | |
| -15.8174% | |
| -7.783% | |
| -31.5821% | |
| 14.4148% | |
| 3.5401% |